| 2025-02-14 | +0.38 % |
|
| 2025-02-13 | -2.75 % |
|
| 2025-02-12 | +1.05 % |
|
| 2025-02-11 | -3.55 % |
|
| 2025-02-07 | -1.88 % |
|
| 2025-02-04 | +0.86 % |
|
| 2025-01-30 | +0.91 % |
|
| 2025-01-29 | -2.93 % |
|
| 2025-01-24 | +0.28 % |
|
| 2025-01-22 | +0.09 % |
|
| 2025-01-16 | -1.32 % |
|
| 2025-01-15 | -1.11 % |
|
| 2025-01-14 | -1.65 % |
|
| 2025-01-13 | +6.81 % |
|
| 2025-01-10 | +0.34 % |
|
| 2025-01-08 | +0.34 % |
|
| 2025-01-06 | +0.69 % |
|
| 2024-12-31 | -0.22 % |
|
| 2024-12-20 | +4.8 % |
|
| 2024-12-19 | -1.7 % |
|
| 2024-12-17 | -10.2 % |
|
| 2024-12-16 | -4.98 % |
|
| 2024-12-13 | +0.49 % |
|
| 2024-12-12 | -1.95 % |
|
| 2024-12-09 | +1.6 % |
|
| 2024-12-06 | -0.47 % |
|
| 2024-12-04 | -1.05 % |
|
| 2024-11-29 | -0.1 % |
|
| 2024-11-25 | +2.04 % |
|
| 2024-11-22 | +0.81 % |
|
| 2024-11-20 | +5.83 % |
|
| 2024-11-19 | +2.37 % |
|
| 2024-11-18 | -1.57 % |
|
| 2024-11-15 | -2.64 % |
|
| 2024-11-13 | +3.34 % |
|
| 2024-11-12 | -0.84 % |
|
| 2024-11-11 | -1.97 % |
|
| 2024-11-06 | +10.71 % |
|
| 2024-11-05 | +1.98 % |
|
| 2024-11-01 | +1.12 % |
|
| 2024-10-31 | -3.19 % |
|
| 2024-10-30 | +3.32 % |
|
| 2024-10-29 | -1.27 % |
|
| 2024-10-28 | +0.14 % |
|
| 2024-10-24 | -0.03 % |
|
| 2024-10-23 | -1.4 % |
|
| 2024-10-22 | +0.67 % |
|
| 2024-10-21 | -2.46 % |
|
| 2024-10-18 | +0.3 % |
|
| 2024-10-17 | +4.21 % |
|
| 2024-10-15 | -3.74 % |
|
| 2024-10-14 | +3.69 % |
|
| 2024-10-11 | +2.64 % |
|
| 2024-10-10 | +2.44 % |
|
| 2024-10-09 | +0.93 % |
|
| 2024-10-08 | +2.92 % |
|
| 2024-10-07 | -1.56 % |
|
| 2024-10-04 | -0.72 % |
|
| 2024-10-03 | -1.91 % |
|
| 2024-10-02 | -11.79 % |
|
| 2024-10-01 | -11.77 % |
- Humana Inc. (NYSE:HUM) experienced a significant decline of 11.77% in its stock value, attributed to a noteworthy rise in short interest and potential concerns among investors regarding the company's future performance and recent trading patterns.
- Humana Inc. (HUM) stock fell by -11.77% due to investor reactions following the disclosure of significant new positions by various firms despite the company reporting strong earnings, hinting at broader market or sentiment pressures rather than company-specific issues.
- Humana (HUM) stock fell by 11.77% last night, likely due to negative market movements and investor sentiment following its earnings report, despite the company exceeding earnings expectations and announcing a dividend.
- Humana (HUM) stock experienced a significant decline of -11.77% following a series of investment reports, despite the company previously reporting strong quarterly earnings. The drop may be attributed to market reactions to the latest analyst ratings, concerns about future growth, or changes in market sentiment towards the healthcare sector.
- Humana Inc. (HUM) stock dropped by 11.77% to a new 52-week low, closing at $300.17, due to market reactions likely spurred by a combination of performance expectations, recent analyst ratings, and broader investor sentiment, despite the company previously beating earnings estimates and reporting revenue growth.
|
| 2024-09-30 | -0.89 % |
|
| 2024-09-27 | +2.09 % |
|
| 2024-09-26 | +0.35 % |
|
| 2024-09-25 | -0.09 % |
|
| 2024-09-24 | -0.17 % |
|
| 2024-09-20 | -0.51 % |
|
| 2024-09-11 | -5.26 % |
|
| 2024-09-09 | -3.94 % |
|
| 2024-09-05 | -1.69 % |
|
